In keeping with the researchers’ hypothesis, these results were maintained at 1 and 6 months post-treatment. ‘Effects sizes from pre-treatment to 6 months follow-up for reductions in dizziness symptoms, disability, and practical impairment were large,’ they state. Furthermore, the reduction in physical symptoms and related disability observed in the existing study was much like those reported for additional remedies, including selective serotonin reuptake inhibitors and vestibular rehabilitation. ‘However, these were achieved following a very brief and noninvasive treatment, ‘ points out the united team.These medications might induce intracranial bleeding along with sudden death, respectively. Insight in to the data of the survey might help lowering redundant and potentially dangerous remedies in AF patients. AF is a regular disorder occurring especially in elderly patients. It could be secondary to hypertension, coronary artery disease, heart failing or valvular cardiovascular disease, but it may also occur in individuals without heart disease. In 2004 a study on AF was carried out in 182 centers from 35 ESC countries. Data was collected on features and management of 5334 patients.